Mechanical Circulatory Support: a Comprehensive Review With a Focus on Women

Manal Alasnag; Alexander G. Truesdell; Holli Williams; Sara C. Martinez; Syeda Kashfi Qadri; John P. Skendelas; William A. Jakobleff; Mirvat Alasnag

doi:10.1007/s11883-020-0828-0

journal article Mar 01, 2020

Mechanical Circulatory Support: a Comprehensive Review With a Focus on Women

Manal Alasnag Alexander G. Truesdell

Holli Williams Sara C. Martinez Syeda Kashfi Qadri John P. Skendelas William A. Jakobleff Mirvat Alasnag

Current Atherosclerosis Reports Vol. 22 No. 3 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/s11883-020-0828-0

Topics

No keywords indexed for this article. Browse by subject →

References

89

[1]

Benjamin E, Virani S, Callaway C, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics – 2018 update: a report from the American Heart Association. Circulation. 2018;137:e67–e492. 10.1161/cir.0000000000000558

[2]

Kolte D, Khera S, Aronow W, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3:e000590. 10.1161/jaha.113.000590

[3]

Jneid H, Fonarow G, Cannon C, et al. Sex differences in medical care and early death after acute myocardial infarction. Circulation. 2008;118:2803–10. 10.1161/circulationaha.108.789800

[4]

•• Mehta L, Beckie T, DeVon H, Grines CL, Krumholz HM, Johnson MN, et al. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016;133:916–47 This statement places research in Women’s Health as a priority & emphasizes areas requiring immediate attention. 10.1161/cir.0000000000000351

[5]

Vahdatpour C, Collins D, Goldberg S. Cardiogenic shock. J Am Heart Assoc. 2019;8:e011991. 10.1161/jaha.119.011991

[6]

Dey S, Flather MD, Devlin G, et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the global registry of acute coronary events. Heart. 2009;95:20–6. 10.1136/hrt.2007.138537

[7]

Habal M, Axsom K, Farr M. Advanced therapies for advanced heart failure in women. Heart Fail Clin. 2019;15:97–107. 10.1016/j.hfc.2018.08.010

[8]

Ali M, Rigopoulos AG, Ali K, et al. Advancements in the diagnostic workup, prognostic evaluation, and treatment of takotsubo syndrome. Heart Fail Rev. 2019. https://doi.org/10.1007/s10741-019-09843-9. 10.1007/s10741-019-09843-9

[9]

Elkayam U, Schäfer A, Chieffo A, Lansky A, Hall S, Arany Z, et al. Use of Impella heart pump for management of women with peripartum cardiogenic shock. Clin Cardiol. 2019;42:clc.23249–981. https://doi.org/10.1002/clc.23249. 10.1002/clc.23249

[10]

Kunadian V, Coats L, Kini AS, Mehran R. Cardiogenic shock in women. Interv Cardiol Clin. 2012;1(2):231–43.

[11]

Acharya D. Predictors of outcomes in myocardial infarction and cardiogenic shock. Cardiol Rev. 2018;26:255–66. 10.1097/crd.0000000000000190

[12]

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. NEJM. 2017;377:2419–32. 10.1056/nejmoa1710261

[13]

•• Tehrani B, Truesdell A, Sherwood M, et al. Standardized team-based care for cardiogenic shock. J Am Coll Cardiol. 2019;73:1659–69 Authors provide management algorythms that have directly impacted CS outcomes in their center. These algorhythms may be replicated in randomized trials. 10.1016/j.jacc.2018.12.084

[14]

• O’Neill W, Grines C, Schreiber T, et al. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. Am Heart J. 2018;202:33–8 The USPELLA registry provides insight into real world outcomes with Impella. 10.1016/j.ahj.2018.03.024

[15]

• Joseph S, Brisco M, Colvin M, et al. Women with cardiogenic shock derive greater benefit from early mechanical circulatory support: an update from the cVAD registry. J Interv Cardiol. 2016;29:248–56 Authors provide data on VAD outcomes. 10.1111/joic.12298

[16]

• Fengler K, Fuernau G, Desch S, et al. Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol. 2015;104:71–8. https://doi.org/10.1007/s00392-014-0767-2. Authors provide data on IABP outcomes. 10.1007/s00392-014-0767-2

[17]

Cowger J, Shash P, Stulak J, et al. INTERMACS profiles and modifiers: heterogeneity of patient classification and the impact of modifiers on predicting patient outcomes. J Heart Lung Transplant. 2016;35:440–8. 10.1016/j.healun.2015.10.037

[18]

Cade JR, Szarf G, de Siqueira MEM, Chaves Á, Andréa JCM, Figueira HR, et al. Pregnancy-associated spontaneous coronary artery dissection: insights from a case series of 13 patients. Eur Heart J Cardiovasc Imaging. 2017;18(1):54–61. 10.1093/ehjci/jew021

[19]

Bugiardini R, Ricci B, Cenko E, et al. Delayed care and mortality among women and men with myocardial infarction. J Am Heart Assoc. 2017;6(8):e005968. Published 2017 Aug 21. https://doi.org/10.1161/JAHA.117.005968. 10.1161/jaha.117.005968

[20]

Liakos M, Parikh P. Gender disparities in presentation, management, and outcomes of acute myocardial infarction. Curr Cardiol Rep. 2018;20:64. 10.1007/s11886-018-1006-7

[21]

• Basir, MB, Kapur, NK, Patel, K, et al. Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative. Catheter Cardiovasc Interv. 2019;93: 1173–1183. https://doi.org/10.1002/ccd.28307. Authors provide management algorythms that have directly impacted CS outcomes in their center. These algorhythms may be replicated in randomized trials. 10.1002/ccd.28307

[22]

•• Udesen N, Moller J, Lindholm M, et al. Rationale and design of DanGer Shock: Danish-German cardiogenic shock trial. Am Heart J. 2019;214:60–8 Data is awaited from this RCT which is the first using Impella in CS. 10.1016/j.ahj.2019.04.019

[23]

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

Holger Thiele, Uwe Zeymer, Franz-Josef Neumann et al.

New England Journal of Medicine 2012 10.1056/nejmoa1208410

[24]

Champney KP, Frederick PD, Bueno H, Parashar S, Foody J, Merz CNB, et al. The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction. Heart. 2009;95:895–9. 10.1136/hrt.2008.155804

[25]

Strom JB, Zhaao Y, Shen C, et al. National Trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock. EuroIntervention. 2018;13:2152–9. 10.4244/eij-d-17-00947

[26]

Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, et al. Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI registry. JACC Cardiovasc Interv. 2016;9(4):341–51. 10.1016/j.jcin.2015.10.039

[27]

•• Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock. Catheter Cardiovasc Interv. 2019;94(1):ccd.28329 This is the SCAI consensus document that finally provided a standardized & universal definition of shock. 10.1002/ccd.28329

[28]

Nohria A, Lewis E, Stevenson LW. Medical Management of Advanced Heart Failure. JAMA. 2002;287(5):628–40. 10.1001/jama.287.5.628

[29]

Bastos MB, Burkhoff D, Maly J, Daemen J, den Uil CA, Ameloot K, et al. Invasive left ventricle pressure–volume analysis: overview and practical clinical implications, Eur Heart J, ehz552, https://doi.org/10.1093/eurheartj/ehz552. 10.1093/eurheartj/ehz552

[30]

Warriner DR, Brown AG, Varma S, Sheridan PJ, Lawford P, Hose DR, et al. Closing the loop: Modelling of heart failure progression from health to end-stage using a meta-analysis of left ventricular pressure-volume loops. PLoS One. 2014;9(12):e114153. 10.1371/journal.pone.0114153

[31]

Truesdell AG, Tehrani B, Singh R, et al. ‘Combat’ approach to cardiogenic shock. Interv Cardiol. 2018;13(2):81–6. https://doi.org/10.15420/icr.2017:35:3. 10.15420/icr.2017:35:3

[32]

Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, et al. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2018;72:173–82. 10.1016/j.jacc.2018.04.051

[33]

Bregman D, Casarella WJ. Percutaneous intraaortic balloon pumping: initial clinical experience. Ann Thorac Surg. 1980;29:153–5. 10.1016/s0003-4975(10)61654-2

[34]

Subramanian VA, Goldstein JE, Sos JA, et al. Preliminary clinical experience with percutaneous intra-aortic balloon pumping. Circulation. 1980;62(Suppl I):I123–9.

[35]

Ferguson JJ, Cohen M, Freedman RJ, Stone GW, Miller MF, Joseph DL, et al. The current practice of intra-aortic balloon Counterpulsation: results from the benchmark registry. J Am Coll Cardiol. 2001;38:1456–62. 10.1016/s0735-1097(01)01553-4

[36]

Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F, Sgura F, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J. 2003;145:700–7. 10.1067/mhj.2003.14

[37]

Briguori C, Airoldi F, Chieffo A, Montorfano M, Carlino M, Sangiorgi GM, et al. Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. Am Heart J. 2006;152:565–72. 10.1016/j.ahj.2006.02.024

[38]

Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, et al. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol. 2006;98:608–12. 10.1016/j.amjcard.2006.03.036

[39]

Curtis JP, Rathore SS, Wang Y, Chen J, Nallamothu BK, Krumholz HM. Use and Effectiveness of Intra-Aortic Balloon Pumps Among Patients Undergoing High Risk Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2012;5:21–30. 10.1161/circoutcomes.110.960385

[40]

Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome*

Roland Prondzinsky, Henning Lemm, Michael Swyter et al.

Critical Care Medicine 2010 10.1097/ccm.0b013e3181b78671

[41]

Thiele H, Zeymer U, Thelemann N, Neumann FJ, Hausleiter J, et al. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction long-term 6-year outcome of the randomized IABP-SHOCK II Trial. Circulation. 2019;139:395–403. 10.1161/circulationaha.118.038201

[42]

Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, et al. Long-term mortality data from the balloon pump–assisted coronary intervention study (BCIS-1) a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation. 2013;127:207–12. 10.1161/circulationaha.112.132209

[43]

Beiras-Fernandez A, Kammerer T, Heinz F, Kur F, Kiessling AH, Weis M, et al. Influence of gender on postoperative outcome after intra-aortic balloon counter-pulsation and cardiac surgery. Thorac Cardiovasc Surg. 2013;61(1):47–51. 10.1055/s-0032-1331405

[44]

Wilczyński M, Krzych LJ, Bis J, Szmagała P, Ulczok R, Bochenek A. Effect of gender on efficacy of preoperative intra-aortic balloon pump in high risk patients undergoing surgical coronary revascularisation. Kardiol Pol. 2010;68(12):1361–8.

[45]

Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR. White HD; the writing group on behalf of the joint ESC/ACCF/AHA/WHF task force for the universal definition of myocardial infarction.Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551–67. 10.1093/eurheartj/ehs184

[46]

O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2013;127:e362–425. 10.1161/cir.0b013e3182742c84

[47]

Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, et al. Concomitant implantation of Impella on top of veno-arterial extracorporeal membrance oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail. 2017;19:404–12. 10.1002/ejhf.668

[48]

• Russo J, Aleksova N, Pitcher I, et al. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock. J Am Coll Cardiol. 2019;73:654–62 Authors provide data for ECMO use. 10.1016/j.jacc.2018.10.085

[49]

Meyns B, Stolonski J, Leunene V, et al. Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol. 2003;41:1087–95. 10.1016/s0735-1097(03)00084-6

[50]

Smalling R, Cassidy D, Barrett R, et al. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. Circulation. 1992;85:1152–9. 10.1161/01.cir.85.3.1152

Showing 50 of 89 references

Cited By

23

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

Birgit Vogel, Monica Acevedo · 2021

The Lancet

Metrics

23

Citations

89

References

Details

Published: Mar 01, 2020
Vol/Issue: 22(3)
License: View

Authors

M

Manal Alasnag

A

Alexander G. Truesdell

Cardiology, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia

Cite This Article

Manal Alasnag, Alexander G. Truesdell, Holli Williams, et al. (2020). Mechanical Circulatory Support: a Comprehensive Review With a Focus on Women. Current Atherosclerosis Reports, 22(3). https://doi.org/10.1007/s11883-020-0828-0

Mechanical Circulatory Support: a Comprehensive Review With a Focus on Women

You May Also Like